Delivery Order SPE2DB22D1002-SPE2DB24FLHQ2

Award Date 9/9/24
Potential Completion Date 9/10/24
Potential Value $4.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the Amerisourcebergen Corporation, to provide Cosentyx, a specialty pharmaceutical medication, at a total ceiling value of $11,668.98. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $14,134.96 firm fixed-price contract provides for the delivery of Cosentyx, a specialty medication used to treat certain autoimmune conditions. The contract has a period of performance through November 13, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA...
This is a $5,674.60 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Cosentyx, a specialty medication. The contract has an ultimate completion date of July 24, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical for providing a comprehensive range of...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Cosentyx, a prescription medication. The contract has a firm fixed price of $24,463.85 and an ultimate completion date of September 4, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical, which...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, to supply Cosentyx medication (300mg dose) with a ceiling value of $16,339.26. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2025, which serves as the primary vehicle for Amerisourcebergen to deliver a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Cosentyx, a specialty medication used to treat certain autoimmune conditions. The contract has a firm-fixed price of $4,885.74 and a completion date of November 20, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract worth $3,458.89 to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract covers the supply of Cosentyx, a prescription medication, to the agency. The order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued up to $999,999,999.00, which serves as the primary vehicle for Amerisourcebergen to deliver a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,723.68 firm fixed-price delivery order is for the supply of Cosentyx, a specialty medication used for various medical conditions. The contract has an ultimate completion date of December 5, 2024. The award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,092.66 firm-fixed-price delivery order is for the supply of Cosentyx, a specialty medication used to treat various medical conditions. The contract has an ultimate completion date of September 13, 2024 and was awarded on September 12, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office Division is for the supply of the pharmaceutical product Cosentyx (300mg dose) to the U.S. government. The single-award Indefinite Delivery Contract (IDC) is with the Defense Logistics Agency (DLA) Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This contract serves as the primary vehicle for Amerisourcebergen to provide a wide range of pharmaceutical products and medical...
  • SPE2DB22D1002
    Indefinite Delivery Contract
  • SPE2DB22D1002-SPE2DB24FLHQ2
    Delivery Order

The U.S. government awarded a $4,565.85 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The contract, awarded by the Defense Logistics Agency (DLA), is for the supply of Cosentyx medication, a specialty biologic drug used to treat certain autoimmune conditions. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables the DLA to efficiently procure a comprehensive range of medical commodities from Amerisourcebergen to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation and is expected to be completed by September 10, 2024.

Generated 12/9/24, 2:00 PM